Eradication of methicillin-susceptible Staphylococcus aureus nasal carriage in patients undergoing dialysis: can fusidic acid be used as an alternative to mupirocin?
- Conditions
- persistent nasal Staphylococcus aureus carriageTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- EUCTR2015-002223-25-BE
- Lead Sponsor
- Ghent University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Patients undergoing chronic hemodialysis (> 18yrs) with persistant nasal MSSA carriage (confirmed on two separate swabs, with at least one week interval).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
MRSA carriage, chronic ambulatory peritoneal dialysis, active infection treated with antistaphylococcal antibiotics
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Can Fucidin(r) ointment (sodium fusicate) be used as an alternative decolonization strategy in patients with persistent MSSA carriage undergoing hemodialysis?;Secondary Objective: - Is recolonization (quickly) observed?<br>- How frequently should patients be decolonized.<br>- Is there emergence of resistance?<br>- What are the risk factors for failure of decolonization;Primary end point(s): difference in eradication of MSSA carriage in the Fucidin-group vs. Bactroban-group;Timepoint(s) of evaluation of this end point: day 8, 10, 15, 60 and 90 (microbiologic evaluation)
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.